LENZ Therapeutics, Inc.
LENZ
$4.73
$0.132.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -126.00M | -109.00M | -82.13M | -58.88M | -52.40M |
| Total Depreciation and Amortization | 453.00K | 362.00K | 287.00K | 205.00K | 90.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.72M | 12.13M | 9.21M | 4.83M | 2.97M |
| Change in Net Operating Assets | -3.07M | 9.80M | 3.46M | 8.62M | 2.12M |
| Cash from Operations | -113.91M | -86.70M | -69.17M | -45.22M | -47.22M |
| Capital Expenditure | -511.00K | -735.00K | -827.00K | -938.00K | -685.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.72M | -60.66M | -74.84M | 3.22M | -54.93M |
| Cash from Investing | -23.23M | -61.40M | -75.67M | 2.28M | -55.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 123.62M | 149.72M | 149.75M | 27.18M | 56.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -13.00K |
| Cash from Financing | 123.62M | 149.72M | 149.75M | 27.18M | 56.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.51M | 1.62M | 4.91M | -15.76M | -46.43M |